IDS reveals diagnostic test supply agreement

IDS has announced that one of its partners – Technogenetics – has signed a contract with A Menarini Designs which will see it supply the firm with tests for the diagnosis of autoimmune diseases.

Through its collaboration with Technogenetics, IDS will work to produce a new automated test system entitled the Zenit RA, as well as a collection of 21 tests for the diagnosis of autoimmune diseases.

The five-year distribution agreement covers the whole of Europe and countries of the former Soviet Union, such as Russia and Ukraine.

Chief executive officer of IDS Roger Duggan commented: “The deal signed between Technogenetics and Menarini significantly expands the route to
market for Technogenetics’ autoimmune products. This can only enhance future sales of IDS-manufactured instruments and ancillary reagents across Europe.”

This news follows the announcement last month that IDS has appointed a new non-executive director – Dr Patrik Olof Dahlen – the current chief executive officer of the point-of-care diagnostics firm Chempaq A/S.